Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: A prospective, double-blinded, randomized controlled trial

Journal of Neurosurgery: Pediatrics

Volumn 2, Issue 2, 2008, Pages 111-117

  Rozzelle, Curtis J ^a   Leonardo, Jody ^a   Li, Veetai ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antimicrobial suture; Cerebrospinal fluid shunt; Randomized controlled trial; Shunt infection; Wound closure

Indexed keywords

PLACEBO; POLYGLACTIN; TRICLOSAN;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID SHUNTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MALE; NEWBORN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SHUNT INFECTION; SUTURE; TREATMENT OUTCOME; WOUND CLOSURE;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; COATED MATERIALS, BIOCOMPATIBLE; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCEPHALUS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYGLACTIN 910; SURGICAL WOUND INFECTION; SUTURES; TIME FACTORS; TRICLOSAN;

EID: 48749120161     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/PED/2008/2/8/111     Document Type: Article

References (52)

1. Akiyama H, Torigoe R, Arata J: Interaction of Staphylococcus aureus cells and silk threads in vitro and in mouse skin. J Dermatol Sci 6:247-257, 1993
2. Ammirati M, Raimondi AJ: Cerebrospinal fluid shunt infections in children. A study on the relationship between the etiology of hydrocephalus, age at the time of shunt placement, and infection rate. Childs Nerv Syst 3:106-109, 1987
3. Barbolt TA: Chemistry and safety of triclosan, and its use as an antimicrobial coating on Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan). Surg Infect (Larchmt) 3 (1 Suppl):S45-S53, 2002
4. Bayston R, Lari J: A study of the sources of infection in colonised shunts. Dev Med Child Neurol 16 (6 Suppl):16-22, 1974
5. Blount JP, Campbell JA, Haines SJ: Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin N Am 4:633-656, 1993
6. Bondurant CP, Jimenez DF: Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 23:254-259, 1995
7. Borges LF: Cerebrospinal fluid shunts interfere with host defenses. Neurosurgery 10:55-60, 1982
8. Chadduck W, Adametz J: Incidence of seizures in patients with myelomeningocele: a multifactorial analysis. Surg Neurol 30:281-285, 1988
9. Choux M, Genitori L, Lang D, Lena G: Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875-880, 1992
10. Chu CC, Williams DF: Effects of physical configuration and chemical structure of suture materials on bacterial adhesion. A possible link to wound infection. Am J Surg 147:197-204, 1984
11. Cochrane DD, Kestle JR: The influence of surgical operative experience on the duration of first ventriculoperitoneal shunt function and infection. Pediatr Neurosurg 38:295-301, 2003
12. Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J Jr, et al: Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43:294-305, 1998
13. Edmiston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD, et al: Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 203:481-489, 2006
14. Elek SD, Conen PE: The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol 38:573-586, 1957
15. Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M, et al: Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg 84:232-236, 2007
16. Ford HR, Jones P, Gaines B, Reblock K, Simpkins DL: Intraoperative handling and wound healing: controlled clinical trial comparing coated VICRYL plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VICRYL suture (coated polyglactin 910 suture). Surg Infect (Larchmt) 6:313-321, 2005
17. Gardner P, Leipzig T, Phillips P: Infections of central nervous system shunts. Med Clin North Am 69:297-314, 1985
18. George R, Leibrock L, Epstein M: Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51:804-811, 1979
19. Gilbert P, McBain AJ: Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan. Surg Infect (Larchmt) 3 (1 Suppl):S55-S63, 2002
20. Gómez-Alonso A, García-Criado FJ, Parreño-Manchado FC, García-Sánchez JE, García-Sánchez E, Parreño-Manchado A, et al: Study of the efficacy of coated VICRYL plus antibacterial suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery. J Infect 54:82-88, 2007
21. Govender ST, Nathoo N, van Dellen JR: Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831-839, 2003
22. Haines SJ, Walters BC: Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis. Neurosurgery 34:87-92, 1994
23. Hampl J, Schierholz J, Jansen B, Aschoff A: In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 133:147-152, 1995
24. Horgan MA, Piatt JH Jr: Shaving of the scalp may increase the rate of infection in CSF shunt surgery. Pediatr Neurosurg 26:180-184, 1997
25. Kan P, Kestle J: Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 23:773-777, 2007
26. Kanev PM, Sheehan JM: Reflections on shunt infection. Pediatr Neurosurg 39:285-290, 2003
27. Katz S, Izhar M, Mirelman D: Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg 194:35-41, 1981
28. Kestle JR, Hoffman HJ, Soloniuk D, Humphreys RP, Drake JM, Hendrick EB: A concerted effort to prevent shunt infection. Childs Nerv Syst 9:163-165, 1993
29. Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, et al: Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 49:441-450, 2000
30. Kontny U, Höfling B, Gutjahr P, Voth D, Schwarz M, Schmitt HJ: CSF shunt infections in children. Infection 21:89-92, 1993
31. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 94:195-201, 2001
32. Langley JM, LeBlanc JC, Drake J, Milner R: Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis 17:98-103, 1993
33. Mancao M, Miller C, Cochrane B, Hoff C, Sauter K, Weber E: Cerebrospinal fluid shunt infections in infants and children in Mobile, Alabama. Acta Paediatr 87:667-670, 1998
34. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ: Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 36:858-862, 2003
35. McLone DG, Czyzewski D, Raimondi AJ, Sommers RC: Central nervous system infections as a limiting factor in the intelligence of children with myelomeningocele. Pediatrics 70:338-342, 1982
36. Moores L, Ellenbogen R: Cerebrospinal fluid shunt infections, in Hall WA, McCutcheon IE (eds): Infections in Neurosurgery. Park Ridge, AANS, 2000, pp 141-154
37. Pattavilakom A, Kotasnas D, Korman TM, Xenos C, Danks A: Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery 58:930-935, 2006
38. Pattavilakom A, Xenos C, Bradfield O, Danks RA: Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci 14:526-531, 2007
39. Pople IK, Bayston R, Hayward RD: Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29-36, 1992
40. Ratilal B, Costa J, Sampaio C: Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev 3:CD005365, 2006
41. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF: Factors causing acute shunt infection. Computer analysis of 1174 operations. J Neurosurg 61:1072-1078, 1984
42. Rothenburger S, Spangler D, Bhende S, Burkley D: In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect (Larchmt) 3 (1 Suppl):S79-S87, 2002
43. Schiff SJ, Oakes WJ: Delayed cerebrospinal-fluid shunt infection in children. Pediatr Neurosci 15:131-135, 1989
44. Sciubba DM, Lin LM, Woodworth GF, McGirt MJ, Carson B, Jallo GI: Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 22 (4):E9, 2007
45. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, et al: Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103 (2 Suppl):131-136, 2005
46. Serlo W, Fernell E, Heikkinen E, Anderson H, von Wendt L: Functions and complications of shunts in different etiologies of childhood hydrocephalus. Childs Nerv Syst 6:92-94, 1990
47. Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J: Origin of organisms infecting ventricular shunts. Neurosurgery 22:868-872, 1988
48. Smith ER, Butler WE, Barker FG II: In-hospital mortality rates after ventriculoperitoneal shunt procedures in the United States, 1998 to 2000: relation to hospital and surgeon volume of care. J Neurosurg 100 (2 Suppl Pediatrics):90-97, 2004
49. Storch M, Scalzo H, Van Lue S, Jacinto G: Physical and functional comparison of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) with Coated VICRYL* Suture (coated polyglactin 910 suture). Surg Infect (Larchmt) 3 (1 Suppl):S65-S77, 2002
50. Storch ML, Rothenburger SJ, Jacinto G: Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect (Larchmt) 5:281-288, 2004
51. Thompson DN, Hartley JC, Hayward RD: Shunt infection: is there a near-miss scenario? J Neurosurg 106 (1 Suppl):15-19, 2007
52. Younger JJ, Simmons JC, Barrett FF: Operative related infection rates for ventriculoperitoneal shunt procedures in a children's hospital. Infect Control 8:67-70, 1987